H

Henry Schein

Global healthcare product distributor and services

Ethics & Compliance Manager

Full-TimeUpdated on 10/23/2026
$99.6k - $155.7k+ Bonus
Senior, Expert
Bachelor's, Master's
Remote in USA
RemoteTravel typically less than 25%.
Risk & ComplianceRegulatory Compliance & Ethics

About the job

Requirements
  • Typically 8 or more years of increasing responsibility and complexity in applicable professional experience.
  • Ethics, compliance, and/or legal experience in an organization subject to pharmaceutical, medical device, or other relevant healthcare compliance laws and regulations is preferred.
  • Life Sciences or Healthcare compliance industry experience is preferred, preferably including anti-bribery and corruption, other customer incentives and marketing structures, data protection, and government contracting.
  • Knowledge of foreign healthcare fraud and abuse laws, relevant data privacy legislation, and experience with transparency reporting are a plus.
  • International working experience is preferred.
  • English and Spanish fluency are required.
  • Strong proficiency with tools, systems, and procedures.
  • Excellent planning and organizational skills and techniques.
  • Excellent independent decision-making, analysis, and problem-solving skills.
  • Outstanding verbal and written communication skills.
  • Excellent presentation and public speaking skills.
  • Excellent interpersonal skills.
  • Excellent conflict resolution skills and ability to deliver difficult messages.
  • Ability to build partnerships at all levels within the company.
  • Good negotiating skills.
  • Ability to resolve complex issues effectively.
  • Project management and consultative skills, and ability to manage a budget.
  • Specialist in multiple technical and/or business skills.
  • Ability to cultivate and develop lasting internal and external customer relations.
Responsibilities
  • Manage and conduct ethics and compliance pre-close due diligence and post-close integration for mergers and acquisitions deals, including acquisitions, investments, and divestitures.
  • Serve as the Ethics and Compliance business partner for LATAM, excluding Brazil, partnering with Business Development, Legal, Regulatory, regional business leaders, and third parties as needed.
  • Participate in special projects and assist with other compliance work as needed.
  • Manage and conduct ethics and compliance due diligence for global acquisitions and investments, covering relevant topics such as data protection and privacy; exclusion and debarment; promotional marketing and claims; email and text marketing campaigns; anti-kickback statutes; Foreign Corrupt Practices Act, anti-corruption, and bribery; transparency reporting of payments and transfers of value to healthcare professionals or entities; telemedicine; and government contracting.
  • Prepare written ethics and compliance due diligence assessments with risk-ranked observations and proposed pre- and post-close remediation plans, and present assessments to internal and external stakeholders.
  • Participate in regular internal deal team meetings and external meetings, such as meetings with underwriters and subject companies.
  • Oversee and manage third-party engagements, including drafting engagement letters, managing budgets, and overseeing deliverables from law firms, consultants, and auditors.
  • Facilitate implementation of pre- and post-closing actions to remediate issues identified during due diligence, including tracking post-closing remediation actions.
  • Prepare reports or presentations, including in Word, Excel, or PowerPoint, for audiences including executive management.
  • Review draft transactional agreements and advise Legal on contract provisions, including indemnification, representations, warranties, covenants, and closing conditions.
  • Notify Ethics and Compliance team members and other appropriate internal teams when acquisitions and investments close to facilitate post-close implementation plans.
  • Analyze new regulatory and legal compliance requirements as needed and determine their impact on M&A deals.
  • Manage, oversee, promote, and enhance the Ethics and Compliance program in LATAM, excluding Brazil, and help ensure companies operate in compliance with applicable laws, regulations, and policies.
  • Serve as a trusted advisor to regional business operations and corporate functions; develop and implement policies, guidelines, education, and communication resources; and lead regional Ethics and Compliance initiatives and projects.
  • Provide advice, support, and guidance to LATAM operations, excluding Brazil, to manage risk and support compliance, respond to management and field/client questions, resolve issues, and promote the company's commitment to compliance and ethical values.
  • Monitor, research, and analyze new regulatory and legal compliance requirements; determine their impact on the company, subsidiaries, and affiliates; prepare summaries and recommendations; and lead implementation plans to meet applicable requirements.
  • Identify, recommend, plan, and assist with implementation of local compliance measures and improvements; lead regional Ethics and Compliance initiatives and projects relating to anti-bribery and corruption, fraud and abuse, customer incentives and marketing structures, data protection, government contracting and tenders, and other matters as requested.
  • Assist with risk assessments or implementation of recommendations, compliance audits, culture surveys, focus groups, and monitoring activities as needed.
  • Assist with internal investigations, business partner and government inquiries and actions, and related responses and resolutions as needed.
  • Assist with compliance Helpline responses, resolutions, and reports as needed.
  • Ensure applicable transparency and other relevant reporting requirements and periodic training requirements are met on time, locally and internationally.
Desired Qualifications
  • A bachelor's degree or global equivalent in a related discipline is typically preferred.
  • A master's degree or global equivalent is preferred.
  • The role may hold two or more industry certifications.

About the company

Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Town of Huntington, New York

Founded

1932

Get referred to Henry Schein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 sales reached $3.5 billion, and management raised full-year guidance.
  • Dentrix Ascend installs tripled since January 2025, with June's record new-customer month.
  • The $1.25 billion credit facility extends to September 19, 2031, funding buybacks and acquisitions.

What critics are saying

  • July 30, 2026 leadership restructuring exits three executives on October 30, 2026.
  • Henry Schein One faces Maryland and Utah lawsuits with filings continuing September 2026.
  • Q2 2026 restructuring expense hit $29 million; repeated charges pressure GAAP earnings.

What makes Henry Schein unique

  • Henry Schein One serves 90% of top 50 DSOs with recurring, high-margin software.
  • One Schein bundles distribution, exclusive brands like Curodont, and practice software.
  • Camlog, Biotech Dental, and Edge strengthen proprietary pricing against commodity distributors.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Company Match
  • Paid Vacation
  • Paid Parental Leave
  • Short Term Disability
  • Health Savings Account/Flexible Spending Account
  • Education Benefits

Growth & Insights and Company News

6 month growth

7%

1 year growth

7%

2 year growth

7%
Yahoo Finance
Sep 30th, 2026
Henry Schein Cares celebrates 25 years with $285M in donations and product contributions

Henry Schein Cares, the corporate citizenship programme of Henry Schein, Inc., is celebrating its 25th anniversary. Since its launch in 2001, the programme has contributed more than $285 million in cash and donated products whilst collaborating with over 5,000 charitable partners worldwide. The programme operates through five pillars: catalysing healthcare access, advancing policies and solutions, relationship building, empowering Team Schein, and sustaining the planet. Key initiatives include supporting the American Dental Association Foundation's Give Kids A Smile programme, which has helped more than 10.2 million underserved children receive oral health services since 2003. Henry Schein celebrated the milestone during UN General Assembly Week in New York City. The company is advancing towards its Net Zero 2050 goal and aims to source 100% renewable energy by 2030.

TipRanks
Sep 22nd, 2026
Henry Schein expands credit facility to $1.25B, extends term to 2031

Henry Schein has amended and restated its revolving credit agreement, expanding aggregate commitments from $1 billion to $1.25 billion. The facility's termination date has been extended to 19 September 2031. The revised facility, arranged with a syndicate of major international banks, adjusts certain financial definitions and covenants. This provides the healthcare distribution company with greater flexibility in its capital structure. Henry Schein intends to use the enlarged credit facility for working capital and general corporate purposes. These include capital expenditures, share repurchases, refinancing existing debt, and funding potential acquisitions. The agreement includes customary representations, warranties, covenants, and events of default. The company supplies dental, medical, and animal health products to office-based practitioners and healthcare organisations in North America and international markets.

Yahoo Finance
Aug 31st, 2026
Henry Schein shares up 13% in Q2 as cost cuts and revenue growth support bullish outlook

MD Sass Concentrated Value Strategy highlighted Henry Schein as a notable contributor in its second-quarter 2026 investor letter. The healthcare solutions provider saw its shares appreciate 13% during the quarter. The asset management firm believes significant cost reductions combined with accelerating revenue growth should lead to material positive earnings revisions moving into the fourth quarter and 2027. MD Sass met with Henry Schein's new chief executive officer, Fred Lowery, and expects his distribution experience and operational approach to improve efficiencies, margins, and market share. The firm's estimates remain well above consensus over the next several years. Henry Schein closed at $89.52 per share on 28 August 2026, with a market capitalisation of $9.98 billion.

Yahoo Finance
Aug 13th, 2026
Henry Schein beats Q2 estimates with $3.46B revenue, raises full-year guidance on dental growth

Henry Schein reported second-quarter results that exceeded Wall Street expectations, with revenue of $3.46 billion versus analyst estimates of $3.37 billion and adjusted EPS of $1.27 versus $1.24 expected. The company attributed the performance to accelerating internal sales growth and robust gains in its global dental merchandise segment. CEO Frederick Lowery highlighted success in converting occasional buyers into regular customers and strong market share gains in the US and Canada. The company slightly raised its full-year adjusted EPS guidance to $5.34 at the midpoint. During the earnings call, analysts questioned the sustainability of US dental consumables growth and the timing of value creation benefits. CFO Ronald South indicated most operating income improvements from these initiatives would materialise in the second half of the year.

Yahoo Finance
Aug 4th, 2026
Henry Schein raises 2026 guidance after Q2 sales hit $3.5B on dental gains

Henry Schein reported second-quarter sales of $3.5 billion, up 6.7% year-over-year, driven by 4.6% internal local-currency growth and foreign exchange benefits. The healthcare distributor raised its full-year guidance following stronger-than-expected performance. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million a year earlier. Non-GAAP earnings reached $1.27 per share, up 15.5% from $1.10 in the prior-year period. Operating margins expanded across all segments. GAAP operating margin increased 27 basis points to 4.94%, whilst non-GAAP operating margin grew 25 basis points to 7.21%. US dental merchandise sales climbed 8.3%, including 6.5% internal growth, with the company reporting market-share gains. Chief Executive Officer Fred Lowery attributed results to operational execution and early benefits from its value-creation programme.